Search

Search Constraints

You searched for: Author/Creator Gelber, Richard D.

Search Results

1. Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT. Issue 7 (1st March 2023)

2. Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials. Issue 7 (1st March 2023)

3. Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up. Issue 13 (1st May 2021)

4. Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial. Issue 21 (20th July 2021)

5. Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations. (October 2021)

6. Clinical behavior of recurrent hormone receptor–positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1‐98 clinical trial. Issue 5 (8th December 2020)

7. Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial. (October 2020)

8. Goserelin for Ovarian Protection During Breast-Cancer Adjuvant Chemotherapy. Issue 6 (June 2015)